Compare SLDP & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SLDP | BME |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Trusts Except Educational Religious and Charitable |
| Sector | Energy | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 552.2M | 576.8M |
| IPO Year | 2021 | 2005 |
| Metric | SLDP | BME |
|---|---|---|
| Price | $1.87 | $48.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.88 | N/A |
| AVG Volume (30 Days) | ★ 3.1M | 42.6K |
| Earning Date | 11-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $21,747,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.35 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.98 | N/A |
| 52 Week Low | $1.80 | $37.51 |
| 52 Week High | $6.35 | $48.30 |
| Indicator | SLDP | BME |
|---|---|---|
| Relative Strength Index (RSI) | 38.28 | 66.16 |
| Support Level | N/A | $41.96 |
| Resistance Level | $2.49 | $48.30 |
| Average True Range (ATR) | 0.12 | 0.83 |
| MACD | -0.00 | 0.15 |
| Stochastic Oscillator | 7.38 | 89.69 |
Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.